The Aβ peptide forms extracellular plaques associated with Alzheimer's disease. In addition to protein fibrils, amyloid plaques also contain non-proteinaceous components, including glycosaminoglycans (GAGs). We have shown previously that the GAG low molecular weight heparin (LMWH) binds to Aβ40 fibrils with a three-fold-symmetric (3Q) morphology with higher affinity than A40 fibrils in alternative structures, Aβ42 fibrils, or amyloid fibrils formed from other sequences. Solid-state NMR (SSNMR) analysis of the GAG-3Q fibril complex revealed an interaction site at the corners of the 3Q fibril structure, but the origin of the binding specificity remained obscure. Here, employing a library of short heparin polysaccharides modified at specific sites, we show that the NS or 6-OS glucosamine sulfates, but not the 2-OS iduronate sulfate, of heparin is required for 3Q binding, indicating selectivity in the interactions of the GAG with the fibril that extends beyond general electrostatic complementarity. By creating 3Q fibrils containing point substitutions in the amino acid sequence, we also show that charged residues at the fibril three-fold apices provide the majority of the binding free energy, while charged residues elsewhere are less critical for binding. The results indicate, therefore, that LMWH binding to 3Q fibrils requires a precise molecular complementarity of the sulfate moieties on the GAG and charged residues displayed on the fibril surface. Differences in GAG binding to fibrils with distinct sequence and/or structure may thus contribute to the diverse etiology and progression of amyloid diseases.
Introduction
Aggregation of proteins and peptides into amyloid fibrils is responsible for more than 50 human diseases [1] . One of the most well-documented amyloid pathologies is Alzheimer's disease (AD) which results from the extracellular deposition of fibrils formed from the Aβ peptide, which ranges from 38 to 43 amino acids in length, along with intracellular deposits of the protein tau [2, 3] . Amyloid plaques also contain an assortment of accessory molecules including nucleic acids [4] , lipids [5] , metal ions [6] , and glycosaminoglycans (GAGs) [7] . GAGs are linear sulfated polysaccharides, which include heparan sulfate (HS), the structure of which varies between mammals and between different tissues [8] , including the brain [9] , and its less ubiquitous, but more homogeneous and highly-sulfated variant, heparin.
Heparin, and its shorter derivative, low molecular weight heparin (LMWH), have been shown to interact with a variety of amyloid proteins in vitro including amylin [10, 11] , α-synuclein [12] , transthyretin [13, 14] , β 2 -microglobulin [15, 16] , gelsolin [17, 18] , tau [19, 20] , and Aβ40/42 [21, 22] . There is also increasing evidence that heparin and other GAGs may be active participants in the formation of amyloid fibrils. Heparin has been shown to accelerate fibril formation [21, 23] , enhance fibril stability [24, 25] and decrease amyloid toxicity [26, 27] . As a consequence, prevention of amyloid:GAG interactions has been considered as an anti-amyloid strategy [28] [29] [30] . In addition to heparin and HS, a number of other natural GAGs have been identified in extracellular amyloid plaques, including chondroitin sulfate [31] [32] [33] , dermatan sulfate [34] , and keratan sulfate [35] , all of which, like heparin and HS, are comprised of sulfated disaccharide units. These sulfate groups are proposed as a requirement for molecular recognition 6 Given the common finding that LMWH co-localizes with amyloid fibrils, we sought here to unravel the determinants of the binding site of LMWH to Aβ40 fibrils of 3Q morphology by altering systematically both the GAG and protein chemistries. The interactions between an array of short heparin molecules containing specific sulfate substitutions and Aβ40 sequence variants assembled by seeding into a 3Q fibril morphology are characterized in detail using in vitro binding assays, complemented by SSNMR. The results reveal the importance of both the GAG substituents and peptide sequence in determining the specific interaction site of LMWH for 3Q fibrils and rationalize why amyloid fibril-GAG interactions are commonly observed in vitro and in vivo [51] [52] [53] .
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Results
Forming A40 3Q fibrils by seeded growth
To investigate LMWH-Aβ40 fibril interactions, A40 fibrils with the 3Q morphology were prepared by seeded elongation of wild-type (WT) 3Q fibril seeds (kindly provided by Tycko [45] ) with Aβ40 monomers uniformly labelled with 13 C and 15 N formed by recombinant expression in E.coli (Methods) [49, 54] . Fibril formation was monitored under quiescent growth conditions using thioflavin T (ThT)
fluorescence and the morphology of the resulting fibrils was assessed using negative stain transmission electron microscopy (TEM). The results showed clear evidence for seeded fibril growth in which an immediate and rapid increase in ThT fluorescence occurs upon the addition of seed under the conditions employed ( Figure 1A ). Negative stain TEM revealed linear, unbranched fibrils ( Figure 1B) , although the fibril 'twist' identified in [45] was not discernible in our hands. SSNMR was used to verify the formation of 3Q fibrils ( Figure 1C -F) [45, 55] . 2D 13 C-
13
C DARR spectra showed sharp and well dispersed resonances, consistent with generation of a specific fibril structure [37, 45, 49] ( Figure 1C , Figure S2 ).
Using these experiments, 95% of the Cα 13 C resonances could be assigned (Table S1 ), although ambiguous 13 C chemical shifts of the isoleucine side-chains were observed, as reported previously [55] .
The chemical shifts obtained correspond closely to previously published values for fibrils of 3Q morphology [45, 49, 55] (Figure 1D ), consistent with the production of fibrils of the 3Q type, with no evidence for formation of other polymorphs or fibrils formed without seeding, which give rise to broad resonances consistent with sample heterogeneity [49] . Previously, 3Q fibrils were shown to differ from other fibril morphologies through a I31-V39 inter-peptide crosspeak, in addition to key intra-peptide crosspeaks F19-I32, F19-V36 and H13-V40 that are more generally characteristic of the loop type structure [45] ( Figure 1E ). In accord with the 3Q morphology, crosspeaks assigned to inter-peptide I31-V39 coupling ( Figure 1E , Figure 1F , top) and crosspeaks assigned to intra-peptide F19-V36 ( Figure 1E , Figure 1F , bottom), H13-V40 and F19-I32 ( Figure 1E , Figure S2 ) coupling were visible in our sample of wild-type 3Q Aβ40 fibrils by SSNMR. These cross-peaks were previously identified and assigned in spectra of selectively 13 C labelled 3Q fibrils ([45] Figure 3 ). These 3Q-seeded Aβ40 fibrils were then used to carry out an analysis of the factors involved in GAG-3Q fibril binding described below.
Sulfate-specific and disaccharide structure-selective interactions of 3Q fibrils with modified heparins
LMWH binding to 3Q fibrils was first examined from the perspective of the disaccharide units from which heparin is composed ( Figure 2A ). Although several studies of GAG binding to amyloid proteins have been performed to date [12, 13, 21, 56] , few have investigated the specificity of the GAG structure on the binding affinity to its target protein [37, 38] . Heparin contains alternating α-D-glucosamine and uronic acid substituents, with sulfate modifications commonly at the 2-O position on α -L-iduronate and the 2-(amino) and 6-O-positions on D-glucosamine ( Figure 2A ). The removal of sulfate groups from heparin and, in the case of N-sulfate, its specific replacement by N-acetyl, can be achieved chemically, producing a library of systematically modified heparin polysaccharides with predominantly homogeneous substitution patterns [57] . These modifications enable detailed exploration of the relationship between charge content and structure of the GAG in determining affinity for 3Q fibrils.
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ACCEPTED MANUSCRIPT 8 Previous work demonstrated that heparin chains above two disaccharide units (dp4) bind 3Q fibrils with similar affinity, with a ΔG° binding of ca. 25 kJ/mol [37] . To investigate the role of different heparin substituents on 3Q binding, a series of modified heparin molecules was created using polysaccharides varying in length from eight to fourteen disaccharide units (dp16-dp28) containing sulfate to hydroxide substitutions at the 2-O-sulfate (2-OS) and/or 6-O-sulfate (6-OS) positions, and/or a variety of substitutions at the 2-N-sulfate (NS) position (removal of sulfate, or substitution with trifluoroacetyl, Figure 2A -B). (Note that the difference in GAG chain length of the modified GAGs examined here does not affect binding affinity [37] ). While the importance of sulfate moieties in amyloid-heparin binding has been noted previously [51, 58] , analysis of the relative importance of individual groups in the affinity of this GAG for amyloid has not been reported.
An in vitro assay was employed to measure the binding affinity of the heparin variants to 3Q fibrils [49] .
In this assay, the concentration of GAG bound to 3Q fibrils was quantified by pelleting GAG-bound fibrils by centrifugation and determining the saccharide content in the supernatant by enzymatic digestion with heparinase II followed by quantification using UV spectroscopy (Methods) [49] . Binding curves were produced from three replicate experiments and the resulting data was fit using the Hill equation to determine an apparent K d of binding ( Figure 2C , Figure 3 , and Figure S3 ). This value was compared with analysis of the binding of dp18 (WT) heparin to 3Q fibrils (K d 30 ± 10 M, Figure 2C -i), and used to compute the difference in K d and hence the ΔΔG° binding for each GAG variant ( Figure 3A -B, Table S2 , Methods). As expected [37, 59] , removal of all negative charges (2-deOS, 6-deOS, deNS NAc) resulted in no detectable binding of the modified GAG to 3Q fibrils ( Figure S3A) . Similarly, the 6-deOS; 2-deOS, 6-deOS; 6-deOS deNS NAc; and deNS, COCF 3 heparin variants failed to bind 3Q fibrils or bound too weakly for a K d to be determined ( Figure 2C -ii, Figure S3B -D, Table S2 ). These results mirror previous findings [36] which have shown that electrostatic interactions are important for GAG-amyloid binding.
Most interesting, however, was the finding that the sulfate groups at each position differ in their effect on 3Q binding. For example, substitution of the 2-O-sulfate with hydroxyl (2-deOS) has no detectable effect
on GAG binding ( Figure S3E ), despite the documented effect that this modification has on both the conformation of the iduronate residue and the geometry of the glycosidic linkage [57, 60, 61] . By contrast, removal of the 6-O-sulfate (6-deOS) reduced affinity to such an extent that binding could not be measured over the concentration range tested ( Figure 2C -ii). While substitution at the 2-OS iduronate position may alter the orientation of the glycosidic linkage, as well as the equilibrium of boat, chair and skew-boat conformations in iduronate, substitution of the 6-OS glucosamine position alters the global heparin conformation less dramatically [57, 60, 61] . Hence, the 6-OS, but not the 2-OS, is required for heparin binding to 3Q fibrils.
A more complex picture emerges from substitution of the glucosamine N-sulfate (NS). Removal of this moiety (deNS) resulted in a small decrease in binding affinity (K d = 54 µM ± 9 µM, Figure S3F ).
Binding is decreased more significantly if the N-sulfate is replaced with N-acetyl (deNS NAc, K d = 95 µM ± 9 µM, Figure S3G) . Surprisingly, replacement of the N-sulfate with N-trifluoroacetyl (deNS COCF 3 ) eliminated binding Figure S3D ). Substitution of two sulfates produced an intermediate effect (2- deOS, deNS NAc, K d = 77 µM ± 7 µM, Figure S3H ), highlighting the importance of specific sulfate moieties in the binding affinity to A40 3Q fibrils and possible compensatory effects of the substitutions [62] . Taken together ( Figure 3A -B), the results show that individual sulfates contribute differently to 3Q:LMWH binding, with the 6-OS being critical, the 2-OS playing a minor role, and the NS group showing substitution-specific effects, pointing to the glucosamine residue as particularly important for dictating binding affinity to 3Q fibrils.
Binding of 3Q fibril mutants to LMWH reveals the role of different residues in GAG binding
In order to assess the heparin-3Q fibril interaction from the perspective of different amino acid sidechains in the fibril structure, single residue substitution variants of Aβ40 were produced and assembled into 3Q fibrils by elongation of WT 3Q seeds with each monomer ( Figure 4A , Figure S4 ). Substitutions were
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10 selected in residues which exhibited significant chemical shift differences upon LMWH binding (≥ 0.4 ppm for Cα/β/γ), including R5, H6, H13, H14, E22, S26, I31, Table S3 ) [49] . Amino acid substitutions implicated in familial Alzheimer's disease (A2T [63] , D7N [64] , A21G [65] , E22Δ [66] , and E22K [67] ) and residues with positively charged sidechains predicted to interact with LMWH (K16, K28) [68] were also included. Neutral residues in regions distant to the proposed heparin binding site were substituted as controls (V18A, M35A, V36A, Table S3 ). In total, residues that are located on the 3Q fibril apices, on the fibril sides and distant from the proposed binding site were assessed, providing good coverage across the fibril structure. In each case the ability of the variant Aβ40 monomer to elongate 3Q fibril seeds was verified by ThT fluorescence ( Figure 4A , Figure S4 ). Although differences in absolute fluorescence intensity were detected between Aβ40 variants presumably due to small structural changes which affect
ThT binding, all variants except M35A ( Figure S4N ) showed the ability to be seeded with 3Q fibrils and were further analyzed for GAG binding. Table S4 ). The weak-binding residues comprise the disordered N-terminal region in the 3Q fibril structure and, with residues K28 and I31 that lie at the start of β-strand 2 (K28A, Figure S7I ; I31T, Figure S7J ; ΔΔG° binding ~ 2.0 kJ/mol), form the 'corners' of the triangular fibril topology that have been predicted previously based on chemical shift perturbations to provide the epicenter of LMWH binding [37, 49] ( Figure 5A -C). Residues H13-K16 located in β-strand 1 form a positive 'stripe' on the fibril exterior that
has been proposed to bind heparin [68] . However, these residues show only moderate changes in ΔΔG° binding (1.1-1.9 kJ/mol) when substituted individually with neutral residues (H13F, H14F, K16A, Figure   4C -ii and -iii, Figure S7E ), ruling out interaction of LMWH with the sides of the 3Q fibrils as the dominant binding surface. Interestingly, residue V36A, which is distant from the proposed binding site supporting the view that GAG:3Q binding involves a specific interface at the fibril 'corners', while other positively charged regions, such as the 'stripe' along the fibril axis formed by the parallel in register stacking of H14 and K16 play a relatively minor role. These results suggest that 3Q:LMWH binding does not simply result from non-specific electrostatic complementarity, but instead relies on precise alignment of positively charged residues with specific sulfate moieties in the GAG itself.
Discussion
Origins of a specific LMWH:3Q fibril interaction
The results described above provide a rationale for the ubiquitous presence of GAGs in amyloid deposits, and also reveal that the interaction between LMWH and 3Q fibrils displays a specificity that extends beyond a simple electrostatic model, involving precise interactions between specific sulfates on the GAG and positively charged residues on the fibril surface (the 'corners' of 3Q fibrils). This cluster of positive charges in the amyloid fibril structure is absent in Aβ40 2A fibrils and other fibril classes with linear arrangements of β-strands, such as Aβ16-22, amylin, and the recently described structures of Aβ42 fibrils [69, 70] , rationalizing the previously identified lower binding affinity of LMWH for these fibril types ( Figure S1 , [37] ). Such precise surface complementarity may explain the fundamentally different binding affinity of GAGs for amyloid fibrils formed from different protein sequences and even for different fibril structures formed from identical or very similar protein sequence variants ( Figure S1 ) [37, 49] .
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A heparin binding site has been mapped previously on Aβ40 fibrils formed de novo which contains a mixtures of different fibril structures, but nonetheless was shown to include residues H13, H14, and K16 [68] . Despite the presumably optimal location of H14 or K16 on the 3Q fibril 'sides' which produces a 'stripe' of positive charge along the fibril axis seeming ideal for binding negatively charged GAGs, independent individual substitutions of H13, H14, and K16 in 3Q fibrils did not eliminate LMWH binding, suggesting that the 'corners' of 3Q fibrils provide a binding site more optimized for interaction with LMWH. In accord with these findings, a recent survey of heparin binding proteins [40] revealed that there is no 'universal' heparin binding motif as such. Rather, short points on the protein surface comprising typically either a positively charged or hydrogen bonding amino acid adjacent to a hydrophobic residue, distributed throughout a particular protein sequence, act as GAG:protein interaction sites, emphasizing the importance of structure in protein-heparin binding. By characterizing variants of both the heparin molecule and protein sequence for the interaction between 3Q fibrils and LMWH, we
show here that binding is dominated by specific residues and substituents on the GAG, notably residues at the 3Q symmetry axis of the fibril and the 6-OS position of the polysaccharide. The 6-OS group, shown here to be an important component of GAG binding to Aβ40 3Q fibrils, has also been demonstrated as a sulfate-dependent regulator of the BACE-1 enzyme, an upstream effector of Aβ production [71] . Hence, as 6-deOS is a poor inhibitor of Aβ production relative to 6-OS heparin, it exerts a double effect on the aggregation cascade: enhancing Aβ formation and limiting heparin binding to the resultant fibrils. Thus, the importance of the 6-OS sulfate group in the GAG has far-reaching consequences which may affect AD manifestation and progression.
While the fibril types studied here are in vitro-derived structures, fibrils with similar three-fold symmetric morphologies have been found in vivo [72] by elongation of plaque material taken from the brain of a patient with AD with monomeric A40. This modelled structure is also three-fold symmetric and contains a cluster of charged amino acids involving residues R5-D7 and S26-K28. From the experiments presented here, we predict that this brain-derived fibril morphology should also bind GAGs with an affinity similar A C C E P T E D M A N U S C R I P T Additional clues about the nature of the compatibility between heparin and Aβ40 were gleaned from the analysis of 16 unrelated crystal structures of protein-heparin complexes, in which the GAG conformation and the proximity of the sulfate groups to different residue types was examined ( Figure 6 , Table S5 ). All GAG ligands examined adopted an approximately linear structure at the protein surface with sulfate groups distributed along the principal (z) axis of inertia with a separation of around 5 Å ( Figure 6A ). This separation mirrors the ~ 4.7 Å repeating distance along the fibril long axis, and so it is reasonable to propose that in the LMWH-3Q complex the GAG orientation is approximately parallel to the fibril axis.
When viewed down the principal axis, the GAG ligands occupy a cross-sectional area of 130 Å 2 , and the sulfate groups cluster into five radial positions ( Figure 6B ). Hence heparin is capable of forming ionic interactions with multiple protein surfaces and, indeed, such a multi-faceted interaction is expected to confer extra stability on the complex. Acidic and basic residues within Aβ are in closest contact with the
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14 ligands and extend into the cross-sectional space and typically within 4 Å of one or more sulfate groups, whereas non-polar/aromatic residues and Thr, Ser and Met tend to be more peripheral ( Figure 6C ). Figure   6D illustrates the cross-sectional area of heparin when mapped onto the heparin binding site at the apices of the 3-fold symmetric 3Q fibril structure. The model implies that heparin can interact simultaneously with an interface formed by the N-and C-termini of one monomer and a second interface formed by the loop region of an adjacent monomer. Further, the interaction site within the heparin cross-sectional space is occupied by acidic and basic residues, allowing intimate contact with the sulfate groups with polar hydrogen bonding residues situated peripherally. Together, these features may explain the uniquely high affinity of heparin for the 3Q morphology while, at the same time, rationalizing the ubiquity of GAG:amyloid interactions observed in vitro and in vivo [56, 73] .
A recent review by Kisilevsky [74] posits that one outstanding question in the amyloid field is whether
GAGs and other co-precipitating plaque components are "associated factors" or "critical components" of aggregation. Previous studies, along with the work presented here, indicate that while GAGs are not required for fibrillation of Aβ40 in vitro, they alter the kinetics of amyloid fibril growth [10, 17, 21, 23] , stabilize fibrils [24, 25] , alter toxicity [52, 73] , and bind extensively and specifically to the fibril surface [37, 49] , potentially competing for interaction with molecular chaperones [75, 76] , metal ions [6, 77] , nucleic acids [78] , and other components known to associate with amyloid fibrils and to affect amyloid formation [79, 80] . GAGs should thus perhaps be considered as "influential participants" in Aβ40 aggregation and deposition. In summary, the results presented suggest a topologically-focused model for GAG-amyloid interactions and indicate that the structural polymorphism exhibited by amyloid fibrils both in vitro [45, 55] and in vivo [41, 72] may affect the interactions of fibrils with key accessory molecules. These co-factors, as a result, may play a significant role in determining disease development, presentation, and progression.
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Materials and Methods
Expression and purification of Aβ40 and its variants.
Commercial Escherichia coli strain BL21 (DE3) cells (Agilent) were transformed with a pETSAC plasmid containing the sequence for Aβ40 [54] and bacteria were grown in MEM (minimal medium for 13 C, 15 N labelled samples) [37] or LB media for unlabelled samples [54] . Cultures were grown and A40 purified as described previously [37, 49] . An identical procedure was used for purification of both labelled and unlabelled samples. The resulting A40 protein contains an additional N-terminal methionine residue that has no effect on the fibrillation of A40 or the morphology of fibrils formed [54] . Final protein concentrations were estimated from UV absorption in 7 M guanidinium chloride at 280 nm using an extinction coefficient of 1490 M -1 cm -1
. Site-directed mutagenesis was performed using a Q5 kit (NEB) to create each variant of A40. Substitutions were verified by plasmid sequencing (BeckmanCoulter Genomics). All variants were expressed and purified as described for the wild-type sequence.
Aβ40 3Q fibril preparation
3Q fibril seeds of Aβ40 were prepared by diluting fibrils of the 3Q morphology [45] (a kind gift from R.
Tycko) to 5% (v/v) in seeding buffer (25 mM NaH 2 PO 4 , pH 7.5, 0.01% (w/v) NaN 3 ) and sonicating for 5 s "on", 45 s "off" for 3 cycles at amplitude 20% (approx. 3 J) to produce seeds. Lyophilized monomeric Aβ40 (or variant) was added to the fibril seeds to a concentration of 0.9 mg/mL and incubated quiescently overnight at 25 °C. After 18 h, the fibrils were sonicated for 5 s, and incubated quiescently at 25 ⁰C for one week. Fibril growth was verified using negative stain TEM.
Seeded fibril growth kinetics monitored by ThT fluorescence
To ensure that 3Q fibrils were forming by seeded elongation of 3Q fibril seeds, fibril growth was monitored using 20 M A40 monomer in the presence or absence of 5% (v/v) 3Q seeds in seeding buffer containing 10 µM ThT. Samples were incubated quiescently at 37 °C in a 96-well plate (Corning 3881)
A C C E P T E D M A N U S C R I P T
ACCEPTED MANUSCRIPT 16 sealed with Star Seal polyolefin film (StarLabs) on a Fluorostar OPTIMA plate reader (BMG Labtech).
Fluorescence was monitored continuously at an excitation wavelength of 440 nm and emission wavelength of 480 nm for a minimum of 3 days. Only samples which clearly demonstrated seeded growth and showed no evidence for spontaneous (unseeded) assembly were taken forwards for analysis of heparin binding. E22 variants, which formed fibrils rapidly under unseeded conditions, showed difference fluorescence intensity and curve shape in unseeded versus seeded samples as shown.
Transmission Electron Microscopy (TEM)
A 10 µL drop of fibril sample was applied to a formvar/carbon-coated copper specimen grid (Agar Scientific Ltd, Stansted, UK.) The drop was blotted with filter paper after 30 s incubation. The grid was then washed with 2 x 10 µL of water and 10 µL 2% (w/v) aqueous uranyl acetate. A second drop of 10 µL 2% uranyl acetate was then applied to the grid and incubated 30 s, then dried at room temperature. Grids were examined in a JEOL JEM-1400 transmission electron microscope in the Astbury Biostructure Laboratory.
Solid-state NMR experiments
Following one week of quiescent growth at 25 ºC, 5 mg total of 0.9 mg/mL fibrils were pelleted by centrifugation at 50000 g for 1 h in an ultracentrifuge (Beckman Coulter) and the supernatant was removed. The pellet was packed in its hydrated state into a 3.2 mm zirconia MAS rotor without further treatment for analysis by SSNMR. 2D 13 C-13 C spectra were recorded at 16.3 T with a 3.2 mm HXY probe operating in double-resonance mode and magic-angle spinning at 14 kHz. The operating temperature was 4 °C. Hartmann-Hahn cross-polarization was achieved with a 2 ms contact time and 100 kHz proton decoupling with SPINAL-64 was applied during signal acquisition. Spectra were recorded with either a 10 ms or 50 ms mixing time during which the proton nutation frequency was adjusted to the MAS frequency of 14 kHz to meet the dipolar-assisted rotational resonance (DARR) condition [81] . Typically,
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
17 480 increments were acquired in the indirect (t 1 ) dimension with 400-600 transients per increment, and the total measurement time varied from 2-7 days depending on the efficiency of rotor packing. Phasesensitive detection in the indirect dimensions was achieved using the States-TPPI method. Chemical shifts are expressed relative to tetramethylsilane. The simulated 13 C-13 C spectrum based on previously published chemical shifts was obtained using a C program written specifically for this purpose.
Preparation of heparin molecules with specific substitutions
Modified heparin derivatives were prepared and characterized as described [57] . N-trifluoroacetyl heparin was prepared from deNS heparin as reported and sized via gel filtration [82] . Unmodified low molecular weight heparin (LMWH) (approx. dp 18) was also purchased from Iduron (Manchester, UK). Purchased 
Quantitation of heparin binding to 3Q fibrils
In vitro binding assays of fibril-heparin binding were performed by quantifying the amount of GAG remaining unbound at different fibril:GAG concentration ratios, as described previously [49] . In brief, fibrils (25 µL of a monomer equivalent concentration of 0.9 mg/mL) were pelleted by centrifugation at standards so as to account for any differences in k cat of heparinase II for different GAG substrates [62] .
The uronic acid content was then determined by measuring the absorbance at 232 nm using an extinction coefficient of 5500 M -1 cm -1 [84] . Three replicates were assayed in parallel, and bound heparin was determined by comparison to replicates of heparin cleavage in the absence of fibrils. Fibril alone (no GAG) and pellet washes were also included in each set. An identical procedure was used to quantify GAG binding to fibril variants and for the heparin variants analyzed here. Binding curves were fitted to the Hill equation: 
where R is the universal gas constant (8.315 J/mol K), T is temperature (298 K), and K d is calculated from equation (1) to yield an apparent free energy of binding ΔG°. This value is then subtracted from the free energy of binding from wild-type 3Q fibrils to LMWH (or dp18) for the change in apparent free energy of binding, ΔΔG°.
Molecular modelling
A C C E P T E D M A N U S C R I P T
Using the structural model of residues 9-40 previously reported in 3Q fibrils (2lmq.pdb [45] ) as a starting point, a model of full length Aβ40 was constructed using Modeller v. 9.13 [85] . Scripts were written to add the flexible N-terminal residues 1-8 missing from 2LMQ, preceded by an additional Met produced by recombinant expression of the peptide. Analysis of heparin-fibril complexes was performed using a C program written specifically for the purpose. Figure S2 and assignments in Table S1 . Figure S3 and Table S2 . Figure S7 and Table S4 . Colors of the panels correspond to the ΔΔG° binding gradient used in Figure 5 . (Table S5) containing bound heparin fragments ranging from dimers to hexamers were compiled and any extraneous A C C E P T E D M A N U S C R I P T
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